126 related articles for article (PubMed ID: 36828794)
1. Physiologically-Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles.
Minnema J; Vandebriel RJ; Boer K; Klerx W; De Jong WH; Delmaar CJE
Small; 2023 May; 19(21):e2207326. PubMed ID: 36828794
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice.
Lin Z; Monteiro-Riviere NA; Riviere JE
Nanotoxicology; 2016; 10(2):162-72. PubMed ID: 25961857
[TBL] [Abstract][Full Text] [Related]
3. Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats.
Chou WC; Cheng YH; Riviere JE; Monteiro-Riviere NA; Kreyling WG; Lin Z
Part Fibre Toxicol; 2022 Jul; 19(1):47. PubMed ID: 35804418
[TBL] [Abstract][Full Text] [Related]
4. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
[TBL] [Abstract][Full Text] [Related]
5. Modeling of clearance, retention, and translocation of inhaled gold nanoparticles in rats.
Krikas A; Neofytou P; Gakis GP; Xiarchos I; Charitidis C; Tran L
Inhal Toxicol; 2022; 34(13-14):361-379. PubMed ID: 36053230
[No Abstract] [Full Text] [Related]
6. Competitive adsorption of thiolated polyethylene glycol and mercaptopropionic acid on gold nanoparticles measured by physical characterization methods.
Tsai DH; DelRio FW; MacCuspie RI; Cho TJ; Zachariah MR; Hackley VA
Langmuir; 2010 Jun; 26(12):10325-33. PubMed ID: 20465235
[TBL] [Abstract][Full Text] [Related]
7. PEG-attached PAMAM dendrimers encapsulating gold nanoparticles: growing gold nanoparticles in the dendrimers for improvement of their photothermal properties.
Umeda Y; Kojima C; Harada A; Horinaka H; Kono K
Bioconjug Chem; 2010 Aug; 21(8):1559-64. PubMed ID: 20666440
[TBL] [Abstract][Full Text] [Related]
8. Modelling the biodistribution of inhaled gold nanoparticles in rats with interspecies extrapolation to humans.
Gakis GP; Krikas A; Neofytou P; Tran L; Charitidis C
Toxicol Appl Pharmacol; 2022 Dec; 457():116322. PubMed ID: 36414120
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation.
Rahimi-Moghaddam F; Azarpira N; Sattarahmady N
Lasers Med Sci; 2018 Nov; 33(8):1769-1779. PubMed ID: 29790012
[TBL] [Abstract][Full Text] [Related]
10. Parameter grouping and co-estimation in physiologically based kinetic models using genetic algorithms.
Tsiros P; Minadakis V; Li D; Sarimveis H
Toxicol Sci; 2024 Jun; 200(1):31-46. PubMed ID: 38637946
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection.
Lipka J; Semmler-Behnke M; Sperling RA; Wenk A; Takenaka S; Schleh C; Kissel T; Parak WJ; Kreyling WG
Biomaterials; 2010 Sep; 31(25):6574-81. PubMed ID: 20542560
[TBL] [Abstract][Full Text] [Related]
12. Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications.
Cole LE; McGinnity TL; Irimata LE; Vargo-Gogola T; Roeder RK
Acta Biomater; 2018 Dec; 82():122-132. PubMed ID: 30316022
[TBL] [Abstract][Full Text] [Related]
13. Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.
Carlander U; Li D; Jolliet O; Emond C; Johanson G
Int J Nanomedicine; 2016; 11():625-40. PubMed ID: 26929620
[TBL] [Abstract][Full Text] [Related]
14. Preparation of near-infrared light absorbing gold nanoparticles using polyethylene glycol-attached dendrimers.
Kojima C; Umeda Y; Harada A; Kono K
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):648-51. PubMed ID: 20801621
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
Paini A; Worth A; Kulkarni S; Ebbrell D; Madden J
Comput Toxicol; 2021 May; 18():100159. PubMed ID: 34027243
[TBL] [Abstract][Full Text] [Related]
16. The fate and toxicity of Raman-active silica-gold nanoparticles in mice.
Thakor AS; Luong R; Paulmurugan R; Lin FI; Kempen P; Zavaleta C; Chu P; Massoud TF; Sinclair R; Gambhir SS
Sci Transl Med; 2011 Apr; 3(79):79ra33. PubMed ID: 21508310
[TBL] [Abstract][Full Text] [Related]
17. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
[TBL] [Abstract][Full Text] [Related]
18. Electrophoretic mobilities of PEGylated gold NPs.
Doane TL; Cheng Y; Babar A; Hill RJ; Burda C
J Am Chem Soc; 2010 Nov; 132(44):15624-31. PubMed ID: 20958038
[TBL] [Abstract][Full Text] [Related]
19. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer.
Kojima C; Umeda Y; Ogawa M; Harada A; Magata Y; Kono K
Nanotechnology; 2010 Jun; 21(24):245104. PubMed ID: 20498528
[TBL] [Abstract][Full Text] [Related]
20. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
